Optimizing rectal cancer management: Analysis of current evidence

Diseases of the Colon and Rectum

Volumn 57, Issue 2, 2014, Pages 252-259

  Monson, John R T ^a   Sharma, A ^b   Dietz, D W ^c   Madoff, R D ^d   Fleshman, J W ^e   Greene, F L ^b   Wexner, S D ^f   Remzi, F H ^g   Abbas, M A ^h   Chang, G J ⁱ   Read, T E ^j   Rothenberger, D A ^k   Garcia Aguilar, J ⁱ   Peters, W ^l   Baxter, N ^m   Beck, D ^b   Bennett, A ^e   Berho, M ^g   Chang, G ⁿ   Efron, J ^o   Fichera, A ^b   Goldblum, J ^j   Guillem, J G ^b   Kalady, M ^p   Kennedy, E ^q   Kosinski, L ^r   Larson, D ⁱ   Lowry, A ^q   Ludwig, K A ^p   MacRae, H M ^b   Merlino, J ^h   Roberts, P ^e   Rosen, L ^k   Safar, B ^k   Whiteford, M ^s   more..

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e DEPARTMENT OF COLORECTAL SURGERY   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k Columbia Surgical ^*

^l ST MICHAEL'S HOSPITAL   (Canada)

^m Ochsner Clinic   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY   (United States)

^o UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^p Mt Sinai UHN Hospitals   (Canada)

^q MEDICAL COLLEGE OF WISCONSIN   (United States)

^r MAYO CLINIC   (United States)

^s Oregon Clinic   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; PATIENT CARE TEAM; PATIENT SELECTION; QUALITY OF HEALTH CARE; RECTAL NEOPLASMS; SPECIALIZATION;

EID: 84893728120     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000020     Document Type: Note

References (75)

1. A merican Cancer Society. National Cancer Database. Atlanta, GA: American Cancer Society; 2007.
2. Colon and rectal cancer. National Cancer Institute website. http://www.cancer.gov/cancertopics/types/colon-and-rectal. Accessed October 30, 2013.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
4. M cArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991;302:1501-1505.
5. F rancisci S, Capocaccia R, Grande E, et al.; EUROCARE Working Group. The cure of cancer: A European perspective. Eur J Cancer. 2009;45:1067-1079.
6. A rchampong D, Borowski D, Wille-Jørgensen P, Iversen LH. Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;(3):CD005391.
7. Kreiter E, Yasui Y, de Gara C, White J, Winget M. Referral rate to oncologists and its variation by hospital for colorectal cancer patients. Ann Surg Oncol. 2012;19:714-721.
8. Wexner SD, Rotholtz NA . Surgeon influenced variables in resectional rectal cancer surgery. Dis Colon Rectum. 2000;43:1606-1627.
9. Ricciardi R, Roberts PL, Read TE, Marcello PW, Schoetz DJ, Baxter NN. Variability in reconstructive procedures following rectal cancer surgery in the United States. Dis Colon Rectum. 2010;53:874-880.
10. E tzioni DA, Cannom RR, Madoff RD, Ault GT, Beart RW Jr. Colorectal procedures: What proportion is performed by American board of colon and rectal surgery-certified surgeons? Dis Colon Rectum. 2010;53:713-720.
11. Ricciardi R, Roberts PL, Read TE, Baxter NN, Marcello PW, Schoetz DJ. Who performs proctectomy for rectal cancer in the United States? Dis Colon Rectum. 2011;54:1210-1215.
12. Verdecchia A, Guzzinati S, Francisci S, et al.; EUROCARE Working Group. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009;45:1042-1066.
13. Craig W, Fisher M, Garcia S, et al. Generalized criteria and evaluation method for center of excellence: A preliminary report. Pittsburgh, PA: Software Engineering Institute Carnegie Mellon University; 2009.
14. What is a center of excellence. Agile Elements website. http://agileelements.wordpress.com/2008/10/29/what-is-a-center-ofexcellence. Accessed October 30, 2013.
15. Gooiker GA, van Gijn W, Wouters MW, Post PN, van de Velde CJ, Tollenaar RA; Signalling Committee Cancer of the Dutch Cancer Society. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg. 2011;98:485-494.
16. Gruen RL, Pitt V, Green S, Parkhill A, Campbell D, Jolley D. The effect of provider case volume on cancer mortality: Systematic review and meta-analysis. CA Cancer J Clin. 2009;59:192-211.
17. Khani MH, Smedh K. Centralization of rectal cancer surgery improves long-term survival. Colorectal Dis. 2010;12:874-879.
18. García-Granero E, Martí-Obiol R, Gómez-Barbadillo J, et al. Impact of surgeon organization and specialization in rectal cancer outcome. Colorectal Dis. 2001;3:179-184.
19. I versen LH, Harling H, Laurberg S, Wille-Jørgensen P; Danish Colorectal Cancer Group. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: A review of evidence: Part 2-long-term outcome. Colorectal Dis. 2007;9:38-46.
20. M ercury Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study. BMJ. 2006;333:779.
21. L ahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: A metaanalysis. Semin Ultrasound CT MR. 2005;26:259-268.
22. N ougaret S, Rouanet P, Molinari N, et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology. 2012;263:409-418.
23. Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D; Royal Marsden Hospital, Colorectal Cancer Network. MRI directed multidisciplinary team preoperative treatment strategy: The way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351-357.
24. L ambregts DM, Maas M, Bakers FC, et al. Long-term followup features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy. Dis Colon Rectum. 2011;54:1521-1528.
25. T aylor A, Sheridan M, McGee S, Halligan S. Preoperative staging of rectal cancer by MRI; results of a UK survey. Clin Radiol. 2005;60:579-586.
26. Chun HK, Choi D, Kim MJ, et al. Preoperative staging of rectal cancer: Comparison of 3-T high-field MRI and endorectal sonography. AJR Am J Roentgenol. 2006;187:1557-1562.
27. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002;45:10-15.
28. M arusch F, Koch A, Schmidt U, et al. Routine use of transrectal ultrasound in rectal carcinoma: Results of a prospective multicenter study. Endoscopy. 2002;34:385-390.
29. Davey K, Heriot AG, Mackay J, et al. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum. 2008;51:997-1003.
30. Påhlman L, Torkzad MR. Rectal cancer staging: Is there an optimal method? Future Oncol. 2011;7:93-100.
31. H urst PA, Prout WG, Kelly JM, Bannister JJ, Walker RT. Local recurrence after low anterior resection using the staple gun. Br J Surg. 1982;69:275-276.
32. Karanjia ND, Schache DJ, North WR, Heald RJ. 'Close shave' in anterior resection. Br J Surg. 1990;77:510-512.
33. H eald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-1482.
34. Qureshi A, Verma A, Ross P, Landau D. Colorectal cancer treatment. Clin Evid (Online). 2010;2010:0401.
35. M aurer CA, Renzulli P, Kull C, et al. The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: Long-term results. Ann Surg Oncol. 2011;18:1899-1906.
36. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol. 2003;4:695-702.
37. Breukink S, Pierie J, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev: 2006;(4):CD005200.
38. Kuhry E, Schwenk WF, Gaupset R, et al. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008;(2):CD003432.
39. deSouza AL, Prasad LM, Ricci J, et al. A comparison of open and robotic total mesorectal excision for rectal adenocarcinoma. Dis Colon Rectum. 2011;54:275-282.
40. T rastulli S, Farinella E, et al. Robotic compared with laparoscopic rectal resection for cancer: Systematic review and meta-analysis of short-term outcome. Colorectal Dis. 2012;14:134-156.
41. M artling A, Holm T, Rutqvist LE, et al. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg. 2005;92:225-229.
42. M aslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007;50:168-175.
43. N agtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-1734.
44. Quirke P, Steele R, Monson J, et al; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828.
45. S enthil Leonard D, Penninckx F, Fieuws S, et al; PROCARE, a multidisciplinary Belgian Project on Cancer of the Rectum. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252:982-988.
46. Senthil M, Trisal V, Paz IB, Lai LL. Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch Surg. 2010;145:840-843.
47. M ekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID; Pathology Review Committee and the Co-operative Clinical Investigators. Lymph node retrieval in rectal cancer is dependent on many factors-the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009;33:1547-1553.
48. Valentini V, Beets-Tan R, Borras JM, et al. Evidence and research in rectal cancer. Radiother Oncol. 2008;87:449-474.
49. S auer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
50. N ational Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Rectal Cancer. Fort Washington, PA: National Comprehensive Cancer Network; 2009.
51. Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2009;(1):CD006041.
52. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199-6206.
53. S tephens RJ, Thompson LC, Quirke P, et al. Impact of shortcourse preoperative radiotherapy for rectal cancer on patients' quality of life: Data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol. 2010;28:4233-4239.
54. Bosset JF, Collette L, Calais G, et al; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114-1123.
55. Wolthuis AM, Penninckx F, Haustermans K, et al. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Ann Surg Oncol. 2012;19:2833-2841.
56. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: Preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011;254:97-102.
57. M aas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29:4633-4640.
58. Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics: Do they work? Cancer. 1997;79:2380-2384.
59. Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: The University of Pennsylvania experience. Cancer. 2001;91:1231-1237.
60. S tephens MR, Lewis WG, Brewster AE, et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus. 2006;19:164-171.
61. Birchall M, Bailey D, King P; South West Cancer Intelligence Service Head and Neck Tumour Panel. Effect of process standards on survival of patients with head and neck cancer in the south and west of England. Br J Cancer. 2004;91:1477-1481.
62. Coory M, Gkolia P, Yang IA, Bowman RV, Fong KM. Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008;60:14-21.
63. T aylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer: What is the evidence? BMJ. 2010;340:c951.
64. M orris E, Haward RA, Gilthorpe MS, Craigs C, Forman D. The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients. Br J Cancer. 2006;95:979-985.
65. Wood JJ, Metcalfe C, Paes A, et al. An evaluation of treatment decisions at a colorectal cancer multi-disciplinary team. Colorectal Dis. 2008;10:769-772.
66. N ational Cancer Action Team, National Cancer Peer Review Programme 2004-2007. National Report: An Overview of the Findings From the Second National Round of Peer Review of Cancer Services in England. London, United Kingdom; National Cancer Action Team; 2008.
67. Dahlberg M, Glimelius B, Påhlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg. 1999;86:379-384.
68. Wibe A, Møller B, Norstein J, et al Norwegian Rectal Cancer Group. A national strategic change in treatment policy for rectal cancer- implementation of total mesorectal excision as routine treatment in Norway: A national audit. Dis Colon Rectum. 2002;45:857-866.
69. Bülow S, Harling H, Iversen LH, Ladelund S; Danish Colorectal Cancer Group. Survival after rectal cancer has improved considerably in Denmark-secondary publication [in Danish]. Ugeskr Laeger. 2009;171:2735-2738.
70. Department of Health. The NHS Cancer Plan: A Plan For Investment, a Plan For Reform. London, United Kingdom; National Health Service; 2000.
71. N ational Cancer Action Team. National Cancer Peer Review Programme. 2006 Manual for Cancer Services. London, United Kingdom; National Cancer Action Team; 2006.
72. N ational Cancer Action Team. National Cancer Peer Review Programme. 2008 Manual for Cancer Services Colorectal Measures. London, United Kingdom; National Cancer Action Team; 2008.
73. N ational Cancer Action Team. National Cancer Peer Review Programme. 2011 Handbook for Cancer Services. London, United Kingdom; National Cancer Action Team; 2011.
74. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg. 2004;91:610-617.
75. Donabedian A. The Definition of Quality and Approaches to Its Assessment. Vol 1. Explorations in Quality Assessment and Monitoring. Ann Arbor, MI: Health Administration Press; 1980.